Fig. 6From: MiR-23b targets cyclin G1 and suppresses ovarian cancer tumorigenesis and progressionMiR-23b inhibited tumor growth in vivo. a Tumor xenograft volume in nude mice treated with hsa-miR-23b was smaller than that in mock-treated mice. b Tumor xenograft growth in miR-23b–treated nude mice was slower than that in the mock group from day 4 and week 2 onwardsBack to article page